Background
Borchardt, Ronald Terrance was born on February 18, 1944 in Wausau, Wisconsin, United States. Son of Martin E. and Helen K. Borchardt.
(This book is based on the proceedings of the symposium en...)
This book is based on the proceedings of the symposium entitled "Di rected Drug Delivery: A Multidisciplinary Problem," which was held in Lawrence, Kansas on October 17-19, 1984. The purpose of the sym posium and this book is to focus on the multidisciplinary nature of drug delivery. Development of a successful drug delivery system re quires contributions from various scientific disciplines, including pharmaceutical chemistry, analytical chemistry, medicinal chemistry, biochemistry, pharmacology, toxicology, and clinical medicine. The contents of this volume illustrate the importance of the various disci plines in identifying the problems and approaches for the develop ment of a rational and effective drug delivery system. Thus the infor mation provided herein will be of value not only to the pharmaceutical chemists who are responsible for dosage form design, but also to the pharmacokineticists, pharmacologists, and clinicians involved in bio logical evaluation of drug delivery systems. The volume should also be of interest to the analytical chemists who must provide technology to quantitcltively evaluate drug delivery. Additionally, this work will also interest the biochemists and medicinal chemists involved in drug dis covery, since the drug delivery system often plays a major role in determining the success or failure of a new drug entity. Each speaker at the symposium was requested to contribute a chapter reviewing the contribution of their major discipline to the de velopment of a successful drug delivery system.
http://www.amazon.com/gp/product/089603089X/?tag=2022091-20
(This book is based on the proceedings of the symposium en...)
This book is based on the proceedings of the symposium entitled "Di rected Drug Delivery: A Multidisciplinary Problem," which was held in Lawrence, Kansas on October 17-19, 1984. The purpose of the sym posium and this book is to focus on the multidisciplinary nature of drug delivery. Development of a successful drug delivery system re quires contributions from various scientific disciplines, including pharmaceutical chemistry, analytical chemistry, medicinal chemistry, biochemistry, pharmacology, toxicology, and clinical medicine. The contents of this volume illustrate the importance of the various disci plines in identifying the problems and approaches for the develop ment of a rational and effective drug delivery system. Thus the infor mation provided herein will be of value not only to the pharmaceutical chemists who are responsible for dosage form design, but also to the pharmacokineticists, pharmacologists, and clinicians involved in bio logical evaluation of drug delivery systems. The volume should also be of interest to the analytical chemists who must provide technology to quantitcltively evaluate drug delivery. Additionally, this work will also interest the biochemists and medicinal chemists involved in drug dis covery, since the drug delivery system often plays a major role in determining the success or failure of a new drug entity. Each speaker at the symposium was requested to contribute a chapter reviewing the contribution of their major discipline to the de velopment of a successful drug delivery system.
http://www.amazon.com/gp/product/146129603X/?tag=2022091-20
(This book has been developed from its earlier and far les...)
This book has been developed from its earlier and far less formal presentment as the proceedings of a symposium entitled The Biochemistry of S-Adenosylmethionine as a Basis for Drug Design that was held at the Solstrand Fjord Hotel in Bergen, Norway on June 30-July 4, 1985. The purpose of the symposium was to bring together scientists from various disciplines (biochemistry, pharmacology, virology, immunology, chemistry, medicine, and so on) to discuss the recent advances that have been made in our understanding of the biological roles of S adenosylmethionine (AdoMet) and to discuss the feasibility of utilizing AdoMet-dependent enzymes as targets for drug design. Thus the information provided herein will be of value not only to basic scientists involved in elucidating the role of AdoMet in biology, but also to medicinal chemists who are using this basic knowledge in the process of drug design. The volume should also be of interest to pharmacologists and clinicians involved in biological evaluation of potential therapeutic agents arising from the efforts of the biochemists and medicinal chemists. Each plenary speaker at the symposium was requested to submit a chapter reviewing recent contributions of their discipline to our base of knowledge about the biological role of AdoMet. Topics covered in this volume include protein and phospholipid methylations (Section A), nucleic acid methyl ations (Section B), the regulation of AdoMet, S-adenosylhomocysteine, and methylthioadenosine metabolism (Section C), clinical aspects of AdoMet (Section D), and the design, synthesis, and biological evaluation of trans methylation inhibitors (Section E).
http://www.amazon.com/gp/product/0896031020/?tag=2022091-20
Borchardt, Ronald Terrance was born on February 18, 1944 in Wausau, Wisconsin, United States. Son of Martin E. and Helen K. Borchardt.
Bachelor of Science in Pharmacy, University Wisconsin, 1967. Doctor of Philosophy in Medical Chemistry, University Kansas, 1970.
Postdoctoral fellow in physical organic chemistry, National Institutes of Health, National Institute Arthritis and Metabolic Diseases, Bethesda, Maryland., 1971; assistant professor department biochemistry, U. Kansas, Lawrence, 1971-1975; associate professor, U. Kansas, Lawrence, 1975-1979; professor, U. Kansas, Lawrence, 1979-1981; director Center for biomedical Research, U. Kansas, Lawrence, 1981-1988; Solon E. Summerfield professor departments medical chemistry and biochemistry, U. Kansas, Lawrence, since 1981; department chairman pharmaceutical chemistry, U. Kansas, Lawrence, since 1983; Victorian professor, Victorian College Pharmacy, Melbourne, Australia, since 1983. Consultant Upjohn Company, Kalamazoo, since 1984, Smith Kline Beecham Pharmaceuticals, Upper Marion, Pennsylvania, since 1993, Alza Corporation, Palo Alto, California, since 1993, GenentechCorp., South San Francisco, since 1993, Rhone-Poulenc Rorer, Collegeville, Pennsylvania, since 1993, Somatogen, Inc., Boulder, Colorado, since 1994, Neurobiol. Technologies, Inc., since 1994, Marion Merrell Dow, since 1995.
(This book has been developed from its earlier and far les...)
(This book has been developed from its earlier and far les...)
(This book is based on the proceedings of the symposium en...)
(This book is based on the proceedings of the symposium en...)
(New)
Fellow American Association for the Advancement of Science, American Association Pharmaceutical Scientists (Achievement award in biotechnology 1993, achievement award in medicinal chemistry 1994). Member American Chemical Society, Society Neuroscis., American Society Pharmacology and Experimental Therapeutics, American Society Biochemistry and Molecular Biology, American Society Cell Biology, Association Pharmaceutical Scientists.
Married Pamela K. Bohl, June 11, 1966. Children: Scott R., Paul M., Kelly C.